ArticleOpen forum infectious diseases2024

Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study.

Collins Ankunda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.